VIGNOLA MARK J. (Chief Financial Officer) sold 18.7% of their position (17.19K shares) of TERNS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $99.0K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 1/6/2025ACC: 0001562180-25-000220
Officer· Chief Financial Officer
Since Feb 2021
-17.19K
Net shares
Net seller
$99.0K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
17.19K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−8.13K
Price / share
$5.72
Trade value
$46.52K
% of position
8.8%
1/2/2025
91.94K→83.81K
Common Stock
Direct
Shares
−9.06K
Price / share
$5.80
Trade value
$52.50K
% of position
10.8%
1/6/2025
83.81K→74.75K
Total
Net shares
−17.19K
Net value
-$99.02K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/2/2025 | S · Sale | −8.13K | $5.72 | $46.52K | 8.8% | 91.94K | 83.81K |
| Common Stock Direct | 1/6/2025 | S · Sale | −9.06K | $5.80 | $52.50K | 10.8% | 83.81K | 74.75K |
| Total | −17.19K | -$99.02K | ||||||
Derivative Transactions0
No derivative transactions reported